Sign in Register

Eysuvis (loteprednol etabonate)

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

Loteprednol etabonate is a synthetic nonfluorinated corticosteroid.

USES: This medication is used for short-term (up to 2 weeks) treatment to help relieve dry eye disease. Loteprednol belongs to a class of drugs known as corticosteroids. It works by decreasing inflammation (swelling).

Generic name: loteprednol etabonate
Pronunciation: (LOE-te-PRED-nol)

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Eysuvis

Intelligence content is not available yet.

Indications

The following indications are listed for Eysuvis:

  • Dry Eye

Also known as: Eye Dryness, Xerophthalmia.

Dosing

Safety and efficacy of ophthalmic suspensions containing loteprednol etabonate alone or in fixed combination with tobramycin have not been established in children younger than 18 years of age.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

There is no enhanced messaging for this drug.

Adverse reactions

There is no enhanced messaging for this drug.

Precautions

No enhanced messaging available.

ICD codes

No ICD codes are available for this drug.

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a 5-digit ZIP code. Searching does not change your profile.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data